Qingyan Li, Jianguo Li, Mengwen Niu, Tianshu Chu, Lemei An
{"title":"血清尿酸升高作为非高血压、非糖尿病合并冠状动脉疾病患者放置多个支架的独立危险因素:一项回顾性队列分析","authors":"Qingyan Li, Jianguo Li, Mengwen Niu, Tianshu Chu, Lemei An","doi":"10.1007/s10067-025-07602-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While the relationship between serum uric acid (SUA) and coronary artery disease (CAD) remains controversial, emerging evidence suggests a particularly significant association in patients lacking traditional cardiovascular risk factors. The specific role of hyperuricemia in determining CAD severity in non-hypertensive, non-diabetic populations warrants further investigation.</p><p><strong>Methods: </strong>In this retrospective cohort study, we analyzed 716 consecutive CAD patients undergoing percutaneous coronary intervention (PCI), with a focus on 279 individuals without hypertension or diabetes. We employed multivariable logistic regression and stratified analyses to assess the independent association between SUA levels and multiple stent implantation (≥ 2 stents), a robust indicator of CAD complexity, and prognosis. Hyperuricemia was defined using gender-specific thresholds (> 420 μmol/L for males and postmenopausal females; > 360 μmol/L for premenopausal females).</p><p><strong>Results: </strong>In the overall cohort, multivessel disease (OR = 2.27, 95% CI 1.94-3.96, p < 0.001) and diabetes (OR = 1.47, 95% CI 1.05-2.07, p = 0.027) independently predicted multiple stent placement. Notably, in the non-hypertensive, non-diabetic subgroup, hyperuricemia emerged as a strong independent predictor (OR = 4.62, 95% CI 1.93-11.07, p = 0.001), exceeding the predictive value of multivessel disease (OR = 3.16, 95% CI 1.78-5.55, p < 0.001). No significant association was observed between SUA levels and stent number in the broader cohort.</p><p><strong>Conclusions: </strong>Elevated serum uric acid independently predicts complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic CAD patients. These findings suggest that uric acid assessment may enhance risk stratification in this specific patient population, warranting further investigation into its clinical implications. Key Points • Elevated serum uric acid is an independent predictor of complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic patients with coronary artery disease, highlighting its potential role in risk stratification for this specific population.</p>","PeriodicalId":10482,"journal":{"name":"Clinical Rheumatology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Elevated serum uric acid as an independent risk factor for multiple stent placement in non-hypertensive, non-diabetic patients with coronary artery disease: a retrospective cohort analysis.\",\"authors\":\"Qingyan Li, Jianguo Li, Mengwen Niu, Tianshu Chu, Lemei An\",\"doi\":\"10.1007/s10067-025-07602-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>While the relationship between serum uric acid (SUA) and coronary artery disease (CAD) remains controversial, emerging evidence suggests a particularly significant association in patients lacking traditional cardiovascular risk factors. The specific role of hyperuricemia in determining CAD severity in non-hypertensive, non-diabetic populations warrants further investigation.</p><p><strong>Methods: </strong>In this retrospective cohort study, we analyzed 716 consecutive CAD patients undergoing percutaneous coronary intervention (PCI), with a focus on 279 individuals without hypertension or diabetes. We employed multivariable logistic regression and stratified analyses to assess the independent association between SUA levels and multiple stent implantation (≥ 2 stents), a robust indicator of CAD complexity, and prognosis. Hyperuricemia was defined using gender-specific thresholds (> 420 μmol/L for males and postmenopausal females; > 360 μmol/L for premenopausal females).</p><p><strong>Results: </strong>In the overall cohort, multivessel disease (OR = 2.27, 95% CI 1.94-3.96, p < 0.001) and diabetes (OR = 1.47, 95% CI 1.05-2.07, p = 0.027) independently predicted multiple stent placement. Notably, in the non-hypertensive, non-diabetic subgroup, hyperuricemia emerged as a strong independent predictor (OR = 4.62, 95% CI 1.93-11.07, p = 0.001), exceeding the predictive value of multivessel disease (OR = 3.16, 95% CI 1.78-5.55, p < 0.001). No significant association was observed between SUA levels and stent number in the broader cohort.</p><p><strong>Conclusions: </strong>Elevated serum uric acid independently predicts complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic CAD patients. These findings suggest that uric acid assessment may enhance risk stratification in this specific patient population, warranting further investigation into its clinical implications. Key Points • Elevated serum uric acid is an independent predictor of complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic patients with coronary artery disease, highlighting its potential role in risk stratification for this specific population.</p>\",\"PeriodicalId\":10482,\"journal\":{\"name\":\"Clinical Rheumatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Rheumatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10067-025-07602-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10067-025-07602-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:虽然血清尿酸(SUA)与冠状动脉疾病(CAD)之间的关系仍存在争议,但新出现的证据表明,在缺乏传统心血管危险因素的患者中,SUA与冠心病之间的关系尤为显著。在非高血压、非糖尿病人群中,高尿酸血症在决定冠心病严重程度中的特殊作用值得进一步研究。方法:在这项回顾性队列研究中,我们分析了716例连续接受经皮冠状动脉介入治疗(PCI)的冠心病患者,其中279例没有高血压或糖尿病。我们采用多变量logistic回归和分层分析来评估SUA水平与多个支架植入(≥2个支架)之间的独立关联,SUA水平是CAD复杂性和预后的一个强有力的指标。高尿酸血症的定义采用性别特异性阈值(男性和绝经后女性>为420 μmol/L;绝经前女性>为360 μmol/L)。结果:在整个队列中,多血管疾病(OR = 2.27, 95% CI 1.94-3.96, p)结论:血清尿酸升高独立预测非高血压、非糖尿病冠心病患者需要放置多个支架的复杂冠状动脉病变。这些发现表明,尿酸评估可能会加强这一特定患者群体的风险分层,值得进一步研究其临床意义。•血清尿酸升高是非高血压、非糖尿病合并冠状动脉疾病患者复杂冠状动脉病变需要放置多个支架的独立预测因子,强调了其在这一特定人群的风险分层中的潜在作用。
Elevated serum uric acid as an independent risk factor for multiple stent placement in non-hypertensive, non-diabetic patients with coronary artery disease: a retrospective cohort analysis.
Background: While the relationship between serum uric acid (SUA) and coronary artery disease (CAD) remains controversial, emerging evidence suggests a particularly significant association in patients lacking traditional cardiovascular risk factors. The specific role of hyperuricemia in determining CAD severity in non-hypertensive, non-diabetic populations warrants further investigation.
Methods: In this retrospective cohort study, we analyzed 716 consecutive CAD patients undergoing percutaneous coronary intervention (PCI), with a focus on 279 individuals without hypertension or diabetes. We employed multivariable logistic regression and stratified analyses to assess the independent association between SUA levels and multiple stent implantation (≥ 2 stents), a robust indicator of CAD complexity, and prognosis. Hyperuricemia was defined using gender-specific thresholds (> 420 μmol/L for males and postmenopausal females; > 360 μmol/L for premenopausal females).
Results: In the overall cohort, multivessel disease (OR = 2.27, 95% CI 1.94-3.96, p < 0.001) and diabetes (OR = 1.47, 95% CI 1.05-2.07, p = 0.027) independently predicted multiple stent placement. Notably, in the non-hypertensive, non-diabetic subgroup, hyperuricemia emerged as a strong independent predictor (OR = 4.62, 95% CI 1.93-11.07, p = 0.001), exceeding the predictive value of multivessel disease (OR = 3.16, 95% CI 1.78-5.55, p < 0.001). No significant association was observed between SUA levels and stent number in the broader cohort.
Conclusions: Elevated serum uric acid independently predicts complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic CAD patients. These findings suggest that uric acid assessment may enhance risk stratification in this specific patient population, warranting further investigation into its clinical implications. Key Points • Elevated serum uric acid is an independent predictor of complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic patients with coronary artery disease, highlighting its potential role in risk stratification for this specific population.
期刊介绍:
Clinical Rheumatology is an international English-language journal devoted to publishing original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level.
The journal succeeds Acta Rheumatologica Belgica, originally founded in 1945 as the official journal of the Belgian Rheumatology Society. Clinical Rheumatology aims to cover all modern trends in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures connected with the inflammatory, immunologic, metabolic, genetic and degenerative soft and hard connective tissue diseases.